Jinyu Bio-technology Co., Ltd. (SHA:600201)
China · Delayed Price · Currency is CNY 12.64
+0.92 (7.85%)
Jul 31, 2026, 3:00 PM CST
Jinyu Bio-technology Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 13,812 | 16,467 | 7,663 | 11,711 | 9,846 | 18,287 | |
Market Cap Growth | 45.12% | 114.89% | -34.56% | 18.94% | -46.16% | -22.27% |
Enterprise Value | 12,596 | 15,279 | 6,475 | 10,150 | 8,877 | 16,727 |
Last Close Price | 12.64 | 15.02 | 6.81 | 10.57 | 8.79 | 15.75 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 136.64 | 164.49 | 70.31 | 41.29 | 46.74 | 47.84 |
Forward PE | 53.47 | 82.58 | 21.05 | 31.48 | 23.75 | 22.33 |
PS Ratio | 9.93 | 11.79 | 6.10 | 7.33 | 6.44 | 10.30 |
PB Ratio | 2.48 | 2.97 | 1.42 | 2.07 | 1.84 | 3.29 |
P/TBV Ratio | 2.82 | 3.44 | 1.62 | 2.34 | 2.10 | 3.82 |
P/FCF Ratio | 88.87 | 84.58 | 38.34 | 82.67 | 63.71 | 114.01 |
P/OCF Ratio | 45.84 | 52.09 | 26.47 | 28.23 | 28.57 | 34.30 |
PEG Ratio | 0.94 | 1.60 | 2.50 | 0.87 | 1.06 | 0.54 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 9.05 | 10.94 | 5.16 | 6.35 | 5.81 | 9.42 |
EV/EBITDA Ratio | 48.31 | 59.82 | 25.66 | 23.22 | 19.69 | 28.59 |
EV/EBIT Ratio | - | 4107.06 | 174.08 | 40.81 | 35.23 | 42.43 |
EV/FCF Ratio | 81.05 | 78.48 | 32.39 | 71.64 | 57.44 | 104.28 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0 | 0 | 0.00 | 0.00 | 0.00 | 0 |
Debt / EBITDA Ratio | 0.00 | 0.01 | 0.07 | 0.01 | 0.02 | 0.00 |
Debt / FCF Ratio | 0.01 | 0.01 | 0.09 | 0.03 | 0.07 | 0.01 |
Net Debt / Equity Ratio | -0.24 | -0.25 | -0.21 | -0.31 | -0.27 | -0.27 |
Net Debt / EBITDA Ratio | -5.09 | -5.42 | -4.59 | -3.99 | -3.20 | -2.59 |
Net Debt / FCF Ratio | -8.48 | -7.11 | -5.80 | -12.32 | -9.33 | -9.46 |
Asset Turnover | 0.21 | 0.21 | 0.18 | 0.24 | 0.24 | 0.28 |
Inventory Turnover | 2.44 | 2.36 | 1.94 | 2.04 | 2.14 | 2.06 |
Quick Ratio | 3.19 | 2.85 | 2.58 | 3.17 | 3.53 | 3.34 |
Current Ratio | 3.66 | 3.25 | 3.02 | 3.59 | 4.07 | 4.01 |
Return on Equity (ROE) | 1.82% | 1.74% | 1.88% | 5.04% | 3.67% | 7.19% |
Return on Assets (ROA) | -0.02% | 0.03% | 0.34% | 2.34% | 2.42% | 3.82% |
Return on Invested Capital (ROIC) | -0.04% | 0.08% | 0.76% | 5.58% | 5.17% | 10.38% |
Return on Capital Employed (ROCE) | 0.00% | 0.10% | 0.60% | 4.10% | 4.40% | 6.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.75% | 0.61% | 1.42% | 2.42% | 2.14% | 2.09% |
FCF Yield | 1.13% | 1.18% | 2.61% | 1.21% | 1.57% | 0.88% |
Dividend Yield | 0.29% | 0.25% | 0.44% | 0.76% | 0.68% | 0.70% |
Payout Ratio | 31.87% | 33.28% | 82.00% | 23.55% | 59.04% | 35.11% |
Buyback Yield / Dilution | -2.56% | -2.06% | 0.10% | 1.61% | 1.39% | 0.35% |
Total Shareholder Return | -2.25% | -1.82% | 0.53% | 2.37% | 2.07% | 1.05% |